| Primary |
| Pain |
16.0% |
| Osteoarthritis |
13.6% |
| Product Used For Unknown Indication |
10.9% |
| Back Pain |
10.5% |
| Rheumatoid Arthritis |
9.5% |
| Hypertension |
5.5% |
| Arthralgia |
5.4% |
| Drug Use For Unknown Indication |
3.3% |
| Arthritis |
3.2% |
| Pyrexia |
2.7% |
| Pain In Extremity |
2.6% |
| Anaesthesia Procedure |
2.2% |
| Juvenile Arthritis |
2.0% |
| Urinary Tract Infection |
2.0% |
| Gout |
1.9% |
| Analgesia |
1.8% |
| Headache |
1.8% |
| Depression |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Musculoskeletal Pain |
1.6% |
|
| Vomiting |
18.0% |
| Weight Decreased |
8.9% |
| Renal Failure Acute |
7.8% |
| Renal Impairment |
5.8% |
| Urticaria |
5.5% |
| Weight Increased |
4.4% |
| Melaena |
4.2% |
| Upper Gastrointestinal Haemorrhage |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Gastrointestinal Haemorrhage |
3.9% |
| Rectal Haemorrhage |
3.9% |
| Syncope |
3.9% |
| Renal Failure |
3.6% |
| Pruritus |
3.3% |
| Tachycardia |
3.3% |
| Abdominal Pain |
3.0% |
| Anaphylactic Reaction |
3.0% |
| Dyspnoea |
3.0% |
| Pain |
3.0% |
| Renal Failure Neonatal |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
26.3% |
| Drug Use For Unknown Indication |
18.2% |
| Rheumatoid Arthritis |
11.6% |
| Pain |
8.0% |
| Hypertension |
6.4% |
| Osteoarthritis |
4.7% |
| Back Pain |
3.7% |
| Prophylaxis |
2.2% |
| Osteoporosis |
2.1% |
| Epididymitis |
2.0% |
| Urinary Tract Infection |
1.8% |
| Depression |
1.7% |
| Arthralgia |
1.6% |
| Cardiac Failure |
1.6% |
| Ill-defined Disorder |
1.4% |
| Postoperative Care |
1.4% |
| Atrial Fibrillation |
1.4% |
| Pyrexia |
1.4% |
| Spinal Osteoarthritis |
1.3% |
| Intentional Overdose |
1.3% |
|
| Renal Failure Acute |
20.8% |
| Vomiting |
13.6% |
| Toxic Epidermal Necrolysis |
5.5% |
| Suicide Attempt |
4.8% |
| Intentional Overdose |
4.5% |
| Rectal Haemorrhage |
4.5% |
| Weight Decreased |
4.3% |
| Weight Increased |
4.1% |
| Angioedema |
3.8% |
| Myocardial Infarction |
3.8% |
| Loss Of Consciousness |
3.6% |
| Rhabdomyolysis |
3.6% |
| Anaphylactic Reaction |
3.3% |
| Tachycardia |
3.3% |
| Gastrointestinal Haemorrhage |
2.9% |
| Renal Failure |
2.9% |
| Diarrhoea |
2.6% |
| Drug Ineffective |
2.6% |
| Melaena |
2.6% |
| White Blood Cell Count Increased |
2.6% |
|
| Concomitant |
| Rheumatoid Arthritis |
26.7% |
| Product Used For Unknown Indication |
20.0% |
| Drug Use For Unknown Indication |
17.8% |
| Pain |
6.3% |
| Prophylaxis |
4.8% |
| Hypertension |
4.6% |
| Osteoporosis |
2.3% |
| Depression |
2.1% |
| Insomnia |
2.1% |
| Psoriatic Arthropathy |
1.5% |
| Diabetes Mellitus |
1.4% |
| Back Pain |
1.4% |
| Hiv Infection |
1.4% |
| Arthritis |
1.3% |
| Constipation |
1.1% |
| Ankylosing Spondylitis |
1.1% |
| Arthralgia |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Non-small Cell Lung Cancer |
1.0% |
| Adverse Event |
0.9% |
|
| Vomiting |
13.2% |
| Pneumonia |
8.5% |
| Weight Decreased |
8.4% |
| Pyrexia |
6.5% |
| Pain |
5.9% |
| Rheumatoid Arthritis |
4.8% |
| Myocardial Infarction |
4.6% |
| Urinary Tract Infection |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Rash |
4.1% |
| Death |
3.9% |
| Nausea |
3.9% |
| Weight Increased |
3.9% |
| Pain In Extremity |
3.8% |
| Pulmonary Embolism |
3.8% |
| Sepsis |
3.7% |
| Dyspnoea |
3.2% |
| Osteoarthritis |
3.2% |
| Joint Swelling |
3.1% |
| Malaise |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
35.4% |
| Hypertension |
10.8% |
| Back Pain |
8.2% |
| Arthralgia |
6.6% |
| Depression |
5.2% |
| Prophylaxis |
4.6% |
| Schizophrenia |
3.9% |
| Rheumatoid Arthritis |
3.6% |
| Deep Vein Thrombosis |
3.3% |
| Dyslipidaemia |
3.0% |
| Contraception |
2.3% |
| Psoriatic Arthropathy |
2.3% |
| Chemotherapy |
2.0% |
| Pain |
1.6% |
| Drug Use For Unknown Indication |
1.3% |
| Infection Prophylaxis |
1.3% |
| Pain In Extremity |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Hepatic Cirrhosis |
1.0% |
| Infection |
1.0% |
|
| Drug Interaction |
30.9% |
| Upper Gastrointestinal Haemorrhage |
10.9% |
| Peritoneal Haemorrhage |
9.1% |
| Nausea |
5.5% |
| Skin Exfoliation |
5.5% |
| Dyspnoea |
3.6% |
| Prostate Cancer |
3.6% |
| Renal Failure Acute |
3.6% |
| Sensory Disturbance |
3.6% |
| Tremor |
3.6% |
| Vomiting |
3.6% |
| Cardiomegaly |
1.8% |
| Confusional State |
1.8% |
| Convulsion |
1.8% |
| Dehydration |
1.8% |
| Ecchymosis |
1.8% |
| Hypersensitivity |
1.8% |
| Hypertensive Crisis |
1.8% |
| Hypovolaemic Shock |
1.8% |
| International Normalised Ratio Increased |
1.8% |
|
